 |
|
Depression and APOEε4 Status in Individuals with Subjective Cognitive Decline: A Meta-Analysis
Yue-ping Huang, Ju-jun Xue, Chao Li, Xi Chen, Hong-juan Fu, Teng Fei, Peng-xiang Bi
Psychiatry Investig. 2020;17(9):858-864. Published online 2020 Aug 28 DOI: https://doi.org/10.30773/pi.2019.0324
|
|
The impact of biomedical innovation on the disability of elderly Medicare recipients, 2013–2019
Frank R. Lichtenberg
Economics of Innovation and New Technology.2024; 33(2): 344. CrossRef Association of the APOE Gene Polymorphism with Depression in White Adults in the WHO “MONICA-Psychosocial” Program
Valery Gafarov, Elena Gromova, Elena Shakhtshneider, Igor Gagulin, Almira Gafarova
Journal of Personalized Medicine.2023; 13(9): 1306. CrossRef PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol
Salvatore Mazzeo, Michael Lassi, Sonia Padiglioni, Alberto Arturo Vergani, Valentina Moschini, Maenia Scarpino, Giulia Giacomucci, Rachele Burali, Carmen Morinelli, Carlo Fabbiani, Giulia Galdo, Lorenzo Gaetano Amato, Silvia Bagnoli, Filippo Emiliani, Ass
BMC Neurology.2023;[Epub] CrossRef Молекулярно-генетические маркеры (ген APOE) и депрессия среди лиц 25–64 лет (международная программа ВОЗ «MONICA-PSYCHOSOCIAL»)
В. В. Гафаров, Е. А. Громова, Е. В. Шахтшнейдер, И. В. Гагулин, А. В. Гафарова
Ateroscleroz.2023; 19(3): 271. CrossRef The Impact of Biopharmaceutical Innovation on Disability, Social Security Recipiency, and Use of Medical Care of U.S. Community Residents, 1998–2015
Frank R. Lichtenberg
Forum for Health Economics and Policy.2022; 24(1): 35. CrossRef
|